Price T Rowe Associates Inc. MD Grows Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Price T Rowe Associates Inc. MD lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 517.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,529,477 shares of the medical device company’s stock after acquiring an additional 2,957,421 shares during the quarter. Price T Rowe Associates Inc. MD owned 1.77% of Cooper Companies worth $324,466,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fulton Bank N.A. boosted its stake in shares of Cooper Companies by 3.0% during the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after acquiring an additional 109 shares in the last quarter. Covestor Ltd raised its position in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock valued at $42,000 after buying an additional 120 shares during the last quarter. Torray Investment Partners LLC raised its holdings in Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after acquiring an additional 132 shares during the last quarter. Mather Group LLC. lifted its position in Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after buying an additional 133 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in shares of Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after acquiring an additional 136 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

COO has been the topic of a number of research analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. JPMorgan Chase & Co. cut their target price on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. BNP Paribas raised Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Finally, Robert W. Baird decreased their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Trading Down 2.0 %

Shares of COO opened at $80.89 on Friday. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The firm has a market capitalization of $16.18 billion, a P/E ratio of 41.48, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock’s fifty day simple moving average is $82.13 and its 200 day simple moving average is $92.78.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.